Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos)-associated distinct purpuric subtype of toxic erythema of chemotherapy: a retrospective review of 54 patients

Published: 28-01-2021| Version 1 | DOI: 10.17632/65cjrm6xkm.1
Contributors:
Joseph Stoll,
Laura Battle ,
Andrea Moy ,
Stephen Dusza ,
Jae Park ,
Martin Tallman,
Justin Taylor,
Alina Markova

Description

Supplemental Appendix

Files